Melanoma in situ

Melanoma in situ (MIS) poses special challenges with regard to histopathology, treatment, and clinical management. The negligible mortality and normal life expectancy associated with patients with MIS should guide treatment for this tumor. Similarly, the approach to treatment should take into account the potential for MIS to transform into invasive melanoma, which has a significant impact on morbidity and mortality. Part II of this continuing medical education article reviews the histologic features, treatment, and management of MIS.

Source: Journal of the American Academy of Dermatology - July 14, 2015 Category: Dermatology Authors: H. William Higgins, Kachiu C. Lee, Anjela Galan, David J. Leffell Tags: Continuing medical education Source Type: research